אמביזום

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Kupi sada

Aktivni sastojci:

AMPHOTERICIN B

Dostupno od:

GILEAD SCIENCES ISRAEL LTD

ATC koda:

J02AA01

Farmaceutski oblik:

אבקה להכנת תרכיז לאינפוזיה

Sastav:

AMPHOTERICIN B 50 MG/VIAL

Administracija rute:

תוך-ורידי

Tip recepta:

מרשם נדרש

Proizveden od:

GILEAD SCIENCES IRELAND UC, IRELAND

Terapijska grupa:

AMPHOTERICIN B

Područje terapije:

AMPHOTERICIN B

Terapijske indikacije:

Antifungal antibiotic for the treatment of severe systemic and/or deep mycoses where toxicity precludes the use of conventional systemic amphotericin B in effective dosages. This drug should not be used to treat the common clinically inapparent forms of fungal disease which show only positive skin or serologic tests. Ambisome is also indicated for the treatment of systemic fungal infections in immunocompromised patients (e.g. patients with AIDS or cancer). Ambisome is also indicated for the primary therapy of visceral leishmaniasis in immunocompetent patients and immunocompromised patients (e.g. HIV positive). Empirical treatment of presumed fungal infection in febrile neutropenic patients.

Datum autorizacije:

2015-02-28

Dokumenti na drugim jezicima

Svojstava lijeka Svojstava lijeka engleski 17-08-2016
Izvješće o ocjeni javnog Izvješće o ocjeni javnog engleski 18-08-2016

Upozorenja za pretraživanje vezana za ovaj proizvod

Pogledajte povijest dokumenata